US Stock MarketDetailed Quotes

Black Diamond Therapeutics (BDTX)

Watchlist
  • 2.750
  • -0.110-3.85%
Close May 15 16:00 ET
  • 2.750
  • +0.000+0.00%
Post 19:35 ET
157.58MMarket Cap-3.67P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Black Diamond Therapeutics (BDTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
70M
0
0
0
70M
0
0
0
0
Operating revenue
--0
--70M
--0
--0
--0
--70M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.22%11.26M
-36.37%50.13M
-43.85%10.26M
-39.45%10.98M
-39.36%13.42M
-23.59%15.47M
-8.88%78.78M
-12.37%18.28M
-24.50%18.13M
10.47%22.13M
Selling and administrative expenses
-14.26%4.26M
-39.67%16.57M
-33.66%3.97M
-32.11%3.54M
-57.17%4.1M
-25.92%4.96M
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
-General and administrative expense
-14.26%4.26M
-39.67%16.57M
-33.66%3.97M
-32.11%3.54M
-57.17%4.1M
-25.92%4.96M
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
Research and development costs
-33.34%7M
-34.60%33.56M
-48.80%6.3M
-42.41%7.44M
-25.78%9.32M
-22.44%10.51M
-13.54%51.31M
-19.57%12.3M
-20.06%12.91M
-4.55%12.56M
Operating profit
-120.65%-11.26M
125.22%19.87M
43.85%-10.26M
39.45%-10.98M
39.36%-13.42M
369.34%54.53M
8.88%-78.78M
12.37%-18.28M
24.50%-18.13M
-10.47%-22.13M
Net non-operating interest income expense
71.93%1.02M
86.11%4.06M
109.56%1.18M
125.58%1.16M
140.95%1.12M
-6.59%595K
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
Non-operating interest income
71.93%1.02M
86.11%4.06M
109.56%1.18M
125.58%1.16M
140.95%1.12M
-6.59%595K
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
Other net income (expense)
-15.31%1.2M
-122.59%-1.56M
-450.03%-6.04M
-36.02%1.32M
-0.91%1.74M
2.38%1.42M
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
Special income (charges)
----
---7.35M
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--7.35M
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-15.31%1.2M
-16.45%5.78M
-24.06%1.31M
-36.02%1.32M
-0.91%1.74M
2.38%1.42M
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
Income before tax
-115.98%-9.04M
132.10%22.37M
5.44%-15.12M
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
Income tax
Net income
-115.98%-9.04M
132.10%22.37M
5.44%-15.12M
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
Net income continuous Operations
-115.98%-9.04M
132.10%22.37M
5.44%-15.12M
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
Minority interest income
Net income attributable to the parent company
-115.98%-9.04M
132.10%22.37M
5.44%-15.12M
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-115.98%-9.04M
132.10%22.37M
5.44%-15.12M
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
Basic earnings per share
-116.00%-0.16
130.71%0.39
3.57%-0.27
46.43%-0.15
47.22%-0.19
385.71%1
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
Diluted earnings per share
-116.33%-0.16
130.71%0.39
3.57%-0.27
46.43%-0.15
47.22%-0.19
380.00%0.98
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 070M00070M0000
Operating revenue --0--70M--0--0--0--70M--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.22%11.26M-36.37%50.13M-43.85%10.26M-39.45%10.98M-39.36%13.42M-23.59%15.47M-8.88%78.78M-12.37%18.28M-24.50%18.13M10.47%22.13M
Selling and administrative expenses -14.26%4.26M-39.67%16.57M-33.66%3.97M-32.11%3.54M-57.17%4.1M-25.92%4.96M1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M
-General and administrative expense -14.26%4.26M-39.67%16.57M-33.66%3.97M-32.11%3.54M-57.17%4.1M-25.92%4.96M1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M
Research and development costs -33.34%7M-34.60%33.56M-48.80%6.3M-42.41%7.44M-25.78%9.32M-22.44%10.51M-13.54%51.31M-19.57%12.3M-20.06%12.91M-4.55%12.56M
Operating profit -120.65%-11.26M125.22%19.87M43.85%-10.26M39.45%-10.98M39.36%-13.42M369.34%54.53M8.88%-78.78M12.37%-18.28M24.50%-18.13M-10.47%-22.13M
Net non-operating interest income expense 71.93%1.02M86.11%4.06M109.56%1.18M125.58%1.16M140.95%1.12M-6.59%595K13.41%2.18M74.38%565K17.54%516K-13.91%464K
Non-operating interest income 71.93%1.02M86.11%4.06M109.56%1.18M125.58%1.16M140.95%1.12M-6.59%595K13.41%2.18M74.38%565K17.54%516K-13.91%464K
Other net income (expense) -15.31%1.2M-122.59%-1.56M-450.03%-6.04M-36.02%1.32M-0.91%1.74M2.38%1.42M230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M
Special income (charges) -------7.35M------------------0------------
-Less:Impairment of capital assets ------7.35M------------------0------------
Other non- operating income (expenses) -15.31%1.2M-16.45%5.78M-24.06%1.31M-36.02%1.32M-0.91%1.74M2.38%1.42M230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M
Income before tax -115.98%-9.04M132.10%22.37M5.44%-15.12M45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M
Income tax
Net income -115.98%-9.04M132.10%22.37M5.44%-15.12M45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M
Net income continuous Operations -115.98%-9.04M132.10%22.37M5.44%-15.12M45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M
Minority interest income
Net income attributable to the parent company -115.98%-9.04M132.10%22.37M5.44%-15.12M45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -115.98%-9.04M132.10%22.37M5.44%-15.12M45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M
Basic earnings per share -116.00%-0.16130.71%0.393.57%-0.2746.43%-0.1547.22%-0.19385.71%132.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.36
Diluted earnings per share -116.33%-0.16130.71%0.393.57%-0.2746.43%-0.1547.22%-0.19380.00%0.9832.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -